# A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers

> **NCT03769454** · PHASE1 · COMPLETED · sponsor: **Panoptes Pharma GmbH** · enrollment: 45 (actual)

## Conditions studied

- Keratoconjunctivitis
- Ocular Surface Disease

## Interventions

- **DRUG:** PP-001
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03769454
- **Lead sponsor:** Panoptes Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-20
- **Primary completion:** 2021-09-15
- **Final completion:** 2022-03-15
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03769454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03769454, "A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03769454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*